Nursing interns enter clinical practice under substantial psychological strain. Anxiety and depression are reported repeatedly among Chinese nursing students, but the positive-screening prevalence during the internship, and its associated factors, have not been synthesised quantitatively. Nine databases (four Chinese, five English) were searched from inception to 28 June 2026 for cross-sectional studies reporting positive-screening rates of anxiety and/or depressive symptoms at validated cut-offs among nursing interns in mainland China. Quality was assessed with the AHRQ checklist. Prevalence was pooled with the Freeman–Tukey double-arcsine transformation in random-effects (REML) models and summarised with 95% prediction intervals ( PIs ); robustness was checked with logit and GLMM models, leave-one-out, quality-restricted and exploratory subgroup analyses, and Begg’s and Egger’s tests. Forty-seven studies were included. Thirty-three reported anxiety screening during the placement at a standard cut-off, covering 10 157 interns: 28.4%, 95% CI 22.8% to 34.4%, I-squared 97.6%, 95% prediction interval roughly 4% to 64%. Only six reported depressive-symptom screening at a standard cut-off, covering 2674 interns: 37.7%, 95% CI 27.3% to 48.8%, I-squared 96.8%, prediction interval roughly 13% to 66%. Most SDS studies scored positive from 50 rather than the standard 53, and pooling all 22 reported depression rates gave 34.4%, 95% CI 29.1% to 40.0%. At this level of variation the prediction intervals are more informative than the summaries, which are not national prevalences. The anxiety summary was robust to transformation, leave-one-out and quality-restricted analyses, with no detectable funnel-plot asymmetry. No exploratory subgroup differed significantly, including internship stage, p = 0.468. Associated factors were too inconsistently defined to pool. Screening rates among nursing interns in mainland China describe a wide, setting-dependent distribution rather than one prevalence, centred near 28% for anxiety and between one third and two fifths for depressive symptoms, but plausibly running from a few per cent to about two thirds in a cohort. The depression estimate rests on few studies that used a standard threshold. The summaries are a benchmark for a specific cohort, not a national figure, and are screening, not diagnostic, rates; prospective measurement with standard instruments and stated thresholds is the priority. PROSPERO CRD420261430366 (registered 22 June 2026).
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: